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Abstract
Improper wound repair of the corneal epithelium can alter refraction of light resulting in impaired vision. We have shown
that ATP is released after injury, activates purinergic receptor signaling pathways and plays a major role in wound closure. In
many cells or tissues, ATP activates P2X7 receptors leading to cation fluxes and cytotoxicity. The corneal epithelium is an
excellent model to study the expression of both the full-length P2X7 form (defined as the canonical receptor) and its
truncated forms. When Ca
2+ mobilization is induced by BzATP, a P2X7 agonist, it is attenuated in the presence of
extracellular Mg
2+ or Zn
2+, negligible in the absence of extracellular Ca
2+, and inhibited by the competitive P2X7 receptor
inhibitor, A438079. BzATP enhanced phosphorylation of ERK. Together these responses indicate the presence of a canonical
or full-length P2X7 receptor. In addition BzATP enhanced epithelial cell migration, and transfection with siRNA to the P2X7
receptor reduced cell migration. Furthermore, sustained activation did not induce dye uptake indicating the presence of
truncated or variant forms that lack the ability to form large pores. Reverse transcription-polymerase chain reaction and
Northern blot analysis revealed a P2X7 splice variant. Western blots identified a full-length and truncated form, and the
expression pattern changed as cultures progressed from monolayer to stratified. Cross-linking gels demonstrated the
presence of homo- and heterotrimers. We examined epithelium from age matched diabetic and non-diabetic corneas
patients and detected a 4-fold increase in P2X7 mRNA from diabetic corneal epithelium compared to non-diabetic controls
and an increased trend in expression of P2X7variant mRNA. Taken together, these data indicate that corneal epithelial cells
express full-length and truncated forms of P2X7, which ultimately allows P2X7 to function as a multifaceted receptor that
can mediate cell proliferation and migration or cell death.
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Introduction
Wound closure and response to disease involve a series of
complex biologic events. Rapid and long-term signals are
generated in response to the release of nucleotides from cells
upon cell stress, mechanical stimulation, ligand binding or injury.
The stimulation can lead to an increase in cytosolic calcium
generated by the activation of purinergic receptors (P2Y or P2X)
through distinct mechanisms. The P2Y receptors are G-protein
coupled, while the ionotropic P2X receptors form cation channels
and allow for the influx of extracellular Ca
2+ [1,2]. Both are
present in corneal epithelial cells where the distinct mechanisms of
increasing intracellular Ca
2+ are displayed [3]. For example
stimulation of the P2Y receptors attenuates the injury induced
calcium wave, while after activation of the P2X7 receptor with
BzATP it is not diminished [3].
The canonical P2X7 receptor (defined as full-length receptor)
contains an extended C-terminus compared to the other P2X
receptors [4]. While the protein was initially hypothesized to be a
cell death inducing receptor, it is now implicated in both
proliferative and death processes, which reflect the expression of
the truncated or full-length receptor respectively. One of the
features of the full-length receptor is its ability to induce the
formation of large non-selective pores in the cell membrane in
response to prolonged or repeated stimulation. The non-specific
pore allows for the passage of organic cations up to 900 Da into
the cell and can be monitored by the uptake of fluorescent dyes [4–
8]. In addition many of the functions of the canonical P2X7
receptor such as membrane blebbing, formation of large pores and
a cytotoxic response depend on protein interactions with specific
domains in the C-terminus [9–11]. In contrast the lack of pore
formation, dye uptake and cytotoxicity is defined as non-canonical
activity and attributed to P2X7 splice variants [10–12].
The cell death induced by activation of the canonical receptor
occurs via import of lethal intracellular Ca
2+ levels, activation of
caspases, and ultimately apoptosis or necrosis [13–18]. In this
regard the P2X7 receptor is implicated in inflammation and is
expressed in immune cells and cells of the central nervous system
[13,19] where it is a mediator of a number of interleukins that may
serve to integrate the response [5,17,20,21]. This is supported by
data demonstrating that P2X7
2/2 mice are resistant to inflam-
mation [22]. However, its activation has been shown to yield a
number of other activities including the growth of human
neuroblastoma cells [23], the increase in mitogenic activity in
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cervical cancer [11,12]. In addition, activation of the receptor has
been shown to result in the phosphorylation of MAP kinase [25–
27]. Still other work has shown that epithelial adhesion to basal
lamina and corneal wound repair in P2X7
2/2 mice is attenuated
[28]. These data indicate that the receptor can play several
different roles that may be attributed to receptor variants.
In this study, we show that corneal epithelial cells display both
canonical and non-canonical responses. BzATP induces a
canonical slow onset Ca
2+ wave, which is absent in Ca
2+ free
media and is attenuated in the presence of Zn
2+ or Mg
2+.I n
contrast, cell migration is enhanced with BzATP, and reduced
significantly in cells transfected with siRNA to the P2X7 receptor.
Furthermore cytotoxic responses and dye uptake were not
detected in confluent cultures upon P2X7 activation, which
correlates with the expression of the P2X7J variant mRNA and
the expression of both 75 and 42 kDa forms. However, in stratified
cell cultures there is a decrease in the expression of the truncated
form, which correlates with uptake of ToPro-3 in the most apical
cells. In addition we demonstrate that the P2X7 mRNA is
increased in diabetic corneal epithelium compared to control.
Together these data indicate that the expression of full length and
truncated forms allows P2X7 to function as a multi-faceted
receptor.
Materials and Methods
Ethics Statement
Healthy and diabetic human donor corneas were purchased
from National Disease Research Interchange (NDRI) with
permission from Cedars-Sinai Medical Center IRB Protocol EX-
1055. NDRI has a human tissue collection protocol that is subject
to National Institutes of Health oversight.
Materials
Keratinocyte serum-free culture medium was obtained from
Invitrogen (Carlsbad, CA), DMEM was from Mediatech, Inc.
(Manassas, VA) and fetal bovine serum (FBS) was from Gemini
bio-products (West Sacramento, CA). Telomerase immortalized
human corneolimbal epithelial (HCLE) cells were a kind gift from
Dr. I. K. Gipson, Schepens Eye Research Institute, Harvard
University (Boston, MA), and IMR90 fibroblasts were from ATCC
(Manassas,VA). The P2X7 antibody was purchased from Alomone
Labs (Jerusalem, Israel). Anti-fade, Fluo-3/AM, pluronic acid,
propidium iodide, and To-Pro 3 were purchased from Invitrogen.
Secondary antibodies (HRP-conjugated goat anti-rabbit and
donkey anti-goat), and protein A agarose were from Santa Cruz
Biotechnology (Santa Cruz, CA). PNGase F was from New
England Biolabs (Ipswich, MA), and the BCA Protein Assay kit
was purchased from Pierce (Rockford, IL). Western blot
chemiluminescence reagent and PVDF membranes were from
Perkin Elmer (Boston, MA). The Oligotex mRNA kit and DNeasy
kit were purchased from Qiagen (Valencia, CA), and the
Fluorescent Caspase-3 Assay kit was from Biotium (Hayward,
CA). The siRNAs directed against P2X7 and P2Y2 were from
Dharmacon (Lafayette, CO). Lipofectamine 2000, anchored oligo-
[DT]20 primer, TRIzol, DNase I, random hexamers, M-MLV
reverse transcriptase, and RNase H were purchased from
Invitrogen, and the master Taq kit for RT-PCR was from Fisher
Scientific (Pittsburgh, PA). TaqMan probes and TaqMan gene
expression master mix for real time RT-PCR were obtained from
Applied Biosystems (Foster City, CA). A 438079 hydrochloride
was purchased from Tocris Bioscience (Ellisville, MO). For
northern blot analysis, [
32P]dCTP was purchased from Perkin
Elmer (Boston, MA). NytranH membrane was from Schleicher and
Schuell Bioscience, Inc. (Keene, NH), the nick translation system
was from Invitrogen, and autoradiographic film was from Kodak
(Rochester, NY). Adenosine triphosphate (ATP), 39-O-(4-benzoyl)
benzoyl adenosine 59-triphosphate (BzATP), ethidium bromide
were purchased from Sigma Aldrich, Inc. (St. Louis, MO) and
other routine chemicals were obtained from American Bioanalyt-
ical (Natick, MA).
Cell culture
HCLE cells were cultured in supplemented keratinocyte serum-
free medium (K-SFM) [29]. Twenty-four hours prior to all
experiments, EGF and BPE were removed. The response of
HCLE cells to injury and Ca
2+ mobilization is similar to primary
epithelial cultures [3,30]. To stratify the cells, cultures were
maintained until they achieved confluence and the media was
switched to DMEM:Ham’s F-12 (1:1) containing elevated Ca
2+
supplemented with FBS and EGF [31]. IMR-90 fibroblasts were
cultured in Eagles Minimal Essential Medium containing 10%
FBS according to the manufacturer’s protocol (ATCC).
Calcium imaging
Once cells achieved confluence, Ca
2+ imaging was performed as
previously described [29]. Experiments were performed either in
complete HEPES-buffered saline, Ca
2+-free HEPES-buffered
saline, or in Mg
2+-free HEPES-buffered saline. Cells were perfused
with HEPES-buffered saline prior to stimulation to establish a base
line fluorescence. Perturbations were made while scanning the
cells every 789 ms. Cells were stimulated with agonists prepared in
HEPES-buffered saline and washed with HEPES-buffered saline
and Ca
2+ dynamics were evaluated [29,32]. A438079 was
included in the fluo-3 solution during the 20 min incubation
prior to experimentation as well as in all flow through solutions.
Reverse transcription-polymerase chain reaction (RTPCR)
Messenger RNA was isolated from corneal epithelial cells using
the Oligotex mRNA Kit according to manufacturer’s directions.
mRNA was annealed with anchored oligo–[DT]20 primer and first
strand cDNA synthesis was carried out with M-MLV reverse
transcriptase. Primers to P2X7 were designed to anneal to
consensus sequences found in all of the known P2X7 variants
and are as follows: forward primer: 59-ACAGGAAGAAGTGC-
GAG TCC-39, reverse primer: 59-GGTAGAGCAGGAGGAAC
TGC-39. Additional primers were designed to specifically amplify
P2X7 variants f and j as both of these variants contain the same
frameshift mutation in exon 8: forward primer: 59-TTTCA-
GATGTGGCAATTCAGATA-39, reverse primer: 59- AAG-
TAGGAG AGGGTTGAGCC -39 [12]. DNA amplification was
carried out for 45 cycles (30 s 95uC, 30 s 60uC, 1 min 72uC)
followed by 10 min at 72uC. The amplified PCR products were
examined on 1.2% agarose gels stained with ethidium bromide
and specificity was confirmed by sequencing performed by
Invitrogen. For amplification of specific P2X7 exons, genomic
DNA was extracted from HCLE cells using the DNeasy kit
according to manufacturer’s instructions. PCR was performed
using the primers listed in Table 1.
Real time RT PCR
Cells were lysed in TRIzol and RNA was extracted according to
manufacturer’s guidelines. Genomic DNA was removed by
incubation with DNase I in the presence of 1 unit/ml RNase
inhibitor. RNA was annealed with random hexamers and first
strand cDNA synthesis was carried out with M-MLV reverse
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reverse transcriptase. The cDNA was treated with RNaseH. Real
time RT-PCR was performed using an ABI 7300 (Applied
Biosystems). The TaqMan
H gene expression assays used were:
Hs00175721_m1 for P2X7, Hs00602525_m1 for P2Y2,
Hs00267404_s1 for P2Y4, Hs00602442.m1 for P2X4,
Hs01032443-m1 for Ki67 and the Eukaryotic 18S rRNA
Endogenous Control (Vic/MGB Probe, Primer Limited Applied
Biosystems). For P2X7J primers described above in RT-PCR, ABI
Sybr green master mix was used. The cycling parameters were as
follows: 50uC 2 min, 95uC 10 min, 45 cycles of 95uC 15 s and
60uC 1 min. Results are presented as relative expression
normalized to 18s rRNA and were calculated using the DDCt
method.
Northern blot analysis
Total RNA was extracted from HCLE cells using 4 M
guanidinium thiocyanate as described [33]. Messenger RNA was
isolated by passing the total RNA twice over an oligo-dT column
to ensure complete removal of rRNA. RNA was resolved by
electrophoresis through a 1.2% agarose gel containing 6%
formaldehyde and transferred to a NytranH filter. Lack of rRNA
contamination in the purified mRNA was confirmed by soaking
the filter in 0.04% methylene blue in 0.5 M N-Acetate, pH 5.2 for
10 min. A 412 bp fragment of P2X7 amplified by PCR was used as
it picked up the canonical form and all variants. The primers used
for amplification are directed against a consensus sequence
described above. The probe was labeled with [
32P]dCTP by the
nick translation method according to manufacturer’s protocol.
The hybridization proceeded at 42uC in a solution containing
0.5% SDS, deionized formamide, 5 mM EDTA, 0.9 M NaCl,
50 mM Na2HPO4 (pH 7.0), and the probe. After hybridization,
the blots were washed twice in 5x SSC, 1% SDS at 37uC for
30 min, followed by twice in 1X SSC, 1% SDS at 37uC for 30 min
and once in 0.1X SSC, 0.1% SDS for 15 min at 60uC and
subjected to autoradiography.
SDS PAGE and Western Blot Analysis
Cells were cultured for 18–24 h before experimentation in K-
SFM lacking growth factors. Cells were either treated with
100 mM BzATP in K-SFM lacking growth factors for specified
times or lysed without treatment as indicated in figure legends.
Cells were rinsed with cold phosphate buffered saline (PBS,
pH 7.4), lysed in 10 mM Tris-HCl (pH 7.4) containing 1% Triton
X-100, 0.5% Nonidet P-40, 150 mM NaCl, 1 mM phenylmethyl-
sulfonyl fluoride (PMSF), and 1 mM sodium orthovanadate
(Na3VO4), and sheared using a 20G needle. Total protein
concentration was determined using a bicinchonic acid (BCA)-
based method. Equivalent amounts of protein (40 mg) from each
sample were subjected to SDS-PAGE and transferred to a
nitrocellulose membrane by the semi-dry method. Nonspecific
binding was blocked with 5% milk in a PBS buffer (137 mM
NaCl, 2.7 mM KCl, 10 mM phosphate, 0.1% Tween-20)
according to Alomone. Membranes were probed with primary
antibody (1:200), washed, and incubated with horseradish
peroxidase-conjugated secondary antibody. The chemilumines-
cence enzymatic reaction was carried out (Denville Scientific, Inc.,
Metuchen, NJ).
In situ Crosslinking
Cells were cultured until confluent and cross-linking was
performed in situ after media was replaced with 10 ml of media
without additives. 270 ml of 37% formaldehyde was added
dropwise with swirling to make a 1% solution for 10 minutes at
room temperature. Glycine (1.0 ml of 1.25 M) was added to
quench the unreacted formaldehyde, swirled and incubated for
5 minutes. Cultures were placed on ice and rinsed twice with ice
cold PBS, scraped in 1.0 ml cold cell lysis buffer [PBS containing
sodium vanadate (0.2 mM) and phenylmethanesulfonyl fluoride
(1mM)] and transfered to a 1.5 ml centrifuge tube. The cell
suspension was spun at 3,000 RPM for 3 min and the pellet was
resuspended in cell lysis buffer and frozen at –20uC. Control
samples were prepared the same way but did not contain
formaldehyde. Protein concentration was determined by BCA
and an equivalent amount of protein (50 mg) was subjected to
SDS-PAGE and transferred for immunoblotting. To maintain the
crosslinks, the sample was heated at 65uC for 5 min while
disruption of the crosslinks was performed by heating samples to
95uC for 20 min in SDS sample buffer.
Dye uptake experiments
HCLE cells were cultured in 8-well glass chamber slides or on
slide coverglass. Slides were placed on the heated stage of a Zeiss
LSM 510 confocal microscope and maintained at 37uC and 5%
CO2 using the Zeiss Environmental Chamber. Cells were treated
with control media, ethidium bromide (EtBr) or ToPro-3 alone in
the presence of 100 mM BzATP. Fluorescent and differential
contrast images were taken continuously (every 789 msec/frame)
for 20 min. The excitation and emission wavelengths were as
follows: for EtBr, ex543 nm,e m 605 nm, and for ToPro-3, ex633 nm
Table 1
Target 59-Forward primer-3
59-Reverse Primer-39
Exon 1 TCAGAATGTGCACCTGAAGC
CCAGTACGTTTCATTTTGCAG
Exon 2 GGCTGTAGATCCTAGGGGAAG
AGTCACACGGAAGCAAGTCA
Exon 3 GTCCGCATTTCTGCTTCTTC
CCCAGCAAGCTGGATTATTA
Exon 4 TGACCTGGGCATCACAAAT
GTGTGCACATTCTGGTGGAT
Exon 5 TAGGACCCAGGACTTTGCAG
CGGGTTGAGTTAATGATGTCC
Exon 6 TTCAGGCTTCTGAGGTTTGG
AGAAGCCTCTGGTCCCACTG
Exon 7 GCCTCTTGGCTGTTTGACAT
TGGAACCTCTCCACCACACT
Exon 8 GTTGCCTTGGAAACCAAAAT
CTATGCAGGGAGATGTCTGG
Exon 9 GCCCCACAGCAGTAATTAGG
GCTGCAGTGAGTGGTAATCCT
Exon 10/11 TAGAACCCAGCGACGTATCC
CCAACAATTGCACGTTGAAG
Exon 12 GGGGCATAAAAGGGACTCCT
TGAGCCAGCTTGTTCAATAGTC
Exon 13 CAGACGTGAGCCACGGTGC
GAACCTAGAACCTGAGGGCT
doi:10.1371/journal.pone.0028541.t001
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and dye uptake.
Cytotoxicity assays
Corneal epithelial cells were cultured to 80% confluence in 8-
well glass chamber slides and incubated for 18–24 hr before
experimentation in K-SFM lacking growth factors. Cells were
treated with BzATP (100 mM), actinomycin D (2 mg/ml), or
control media for 15 min, 4 hr, or 20 hr. The NucView TM 488
caspase-3 substrate (ex 488 nm,e m530 nm) was resuspended in
unsupplemented K-SFM to a final concentration of 5 mM. After
the treatment, the media was replaced with the caspase-3 substrate
solution and cells were incubated further for 15 min at room
temperature prior to imaging according to manufacturer’s
directions (Biotium, Hayward, CA). Fluorescence was visualized
on the Zeiss LSM 510 200M microscope. For the MTT assay,
MTT reagent was added for an additional 2 hrs following
treatment with BzATP or actinomycin D, formazan was
solubilized in 0.1 N HCl in isopropanol, and absorbance at
570 nm was measured. Absorbance at 690 nm was measured as
background; final readings are 570 nm minus 690 nm.
Chemotactic migration assay
The transwell migration assay was performed as described
[3,38]. Migration was performed at 37uC and 5% CO2 for
8 hours. Migrated cells were fixed with methanol, stained with
5 mg/ml propidium iodide and membranes were mounted onto
glass slides. For each membrane (33.2 mm
2), the total numbers of
cells were counted in 6 random 10x fields (one field
=1.3761.08 mm, or 1.48 mm
2) and an average and standard
error were calculated.
siRNA transfection
HCLE cells were transfected at 30–50% confluence, 24 hr
following passage. Prior to addition of transfection reagents,
complete media were replaced with K-SFM lacking antibiotics
and supplements (transfection media). The siRNA sequences
directed against P2X7 were sense: 59- GGAUCCAGAGCAU-
GAAUUAUU -39, anti-sense: 59- UAAUUCAUGCUCUG-
GAUCCUU -39 and against P2Y2: sense: 59- GAACUGACA
GCAGAGGAUUU -39, anti-sense: 59- AUCCUCUGCAUGU-
CAGUUCUU -39. A final concentration of 100 nM siRNA or an
equal concentration of non-targeting siRNA (Dharmacon product
# D-001206-13-20) was transfected using 2 mg/ml Lipofectamine
2000 according to manufacturer’s protocol. The transfection
media and reagents were replaced with complete K-SFM 6 hr post
transfection, and the cells were cultured for 4 days prior to
experimentation, which was optimized previously [30].
Scratch wound assay
Corneal epithelial cells were passed into 8-well glass chamber
slides and transfected with either P2X7 siRNA or a non-targeting
control siRNA as described and imaged as described by
[29,30,32,34,35]. Briefly, cells were incubated at 37uC and 5%
CO2 using the Zeiss environmental chamber for 20 h. Two
wounds were made per well and cells were incubated in the
presence or absence of BzATP. After 20 h, the images were
concatenated using the Zeiss LSM 510 Multi-Time software, and
the LSM 510 software was used to measure changes in the wound
area over time. Percent change in wounded area was calculated.
Repeats were performed within runs and between runs to assess
consistency and representative data are shown. Statistical
comparisons were made using Student’s t-test or ANOVA
followed by Tukey’s post hoc test.
Human tissue
Healthy and diabetic human donor eyes and corneas were
purchased from National Disease Research Interchange (NDRI,
Philadelphia, PA), under Cedars-Sinai Medical Center IRB
protocol EX-1055 (see Ethical Statement). Upon receipt, central
corneal buttons were cut out with an 8.25-mm trephine,
epithelium removed and tissue immediately frozen in liquid
nitrogen and RNA isolated. A total of 12 corneas were used (6
non-diabetic, mean age 69y and 6 diabetic, mean age 75y).
Statistics
Statistical comparisons were made using linear regression,
Student’s t-test or Analysis of Variance (ANOVA) followed by
Tukey-Kramer posthoc test or Tukey posthoc test.
Results
BzATP induces mobilization of extracellular Ca
2+ -a
canonical activity of the P2X7 receptor
Previously we demonstrated that confluent corneal epithelial
cells responded to BzATP and determined the EC50 for BzATP
in human corneal epithelial cells to be (8.965.9) 610
25 M using
live cell Ca
2+ imaging [3]. To perform these experiments, cells
were loaded with Fluo-3AM, were stimulated with a constant
flow of agonist in HEPES buffered saline. Change in fluorescence
was measured relative to the basal level [3]. The flow rate was set
so that HEPES alone did not stimulate any response. We
compared the response to BzATP under different ionic
conditions. When cells were stimulated with 100 mMB z A T P ,
there was a significant increase in fluorescence (Figure 1A). In
contrast, when experiments were performed in a calcium-free
HEPES buffer, there was a minimal increase in fluorescence in
response to BzATP (1.83%) (Figure 1A). This result indicates that
Figure 1. BzATP causes an increase in intracellular Ca
2+. HCLE cells were incubated in 5 mM fluo-3AM for 30 min and imaged in a flow-through
apparatus on a Zeiss LSM 510 confocal microscope. Cells were washed with indicated HEPES-buffered saline (control, Ca
2+ free, 4 mM Mg
2+, 100 mM
ZnSO4) and stimulated with BzATP in corresponding buffer for 2 min. Maximal percent change in average fluorescence of a 460 mm6460 mm field
was determined. A. HCLE cells stimulated with BzATP in HEPES buffer, in Ca
2+ free - HEPES buffer, in HEPES buffer with Mg
2+ and in HEPES buffer with
Zn
2+. Graphs represent a minimum of six independent experiments +/2 SEM. Analysis of variance was determined using the general linear model
procedure followed by Tukey-Kramer posthoc test. **p,0.001. B. Response of HCLE cells to ATP followed by stimulation with BzATP. Representative
trace of changes in fluorescence over time. Graph represents difference between stimulation with ATP and BzATP after ATP and represents a
minimum of six independent experiments +/2 SEM. Students t-test ** p,0.001. C Response of HCLE cells to BzATP followed by ATP. Representative
trace of changes in fluoresence over time. Graph represents difference between stimulation with BzATP and ATP after BzATP and represents a
minimum of six independent experiments +/2 SEM. D. Cells were washed with HEPES buffered saline with the indicated concentrations of A438079
and stimulated with BzATP or equimolar concentrations of ADP for 2 min in the presence or absence of inhibitor. The average maximum percent
change in fluorescence is graphed as a percentage of the uninhibited control +/2 SEM. Each time point is an average of 12 independent experiments.
Linear regression analysis where the slope of the line for BzATP is significantly different from 0. p=0.0001. The control ADP is not significantly
different from 0.
doi:10.1371/journal.pone.0028541.g001
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5 min, lysed and equivalent amounts of protein were resolved by SDS-PAGE and immunoblotted with anti-p-ERK. Blots were stripped and reprobed
with anti-ERK and pERK normalized to ERK. Significance was determined by Student’s test (p,0.05). Blot is representative of 3 independent
experiments. B. Transwell migration assays were performed for 8 hr in the presence of BzATP or binding buffer (control). Migrated cells were stained
with propidium iodide, counted in 6 randomly chosen fields (1.48 mm
2) and averaged. Data are representative of 3 independent experiments and are
presented as mean +/2 SEM. Significance was determined by Student’s t-test: **p,0.001. C. Downregulation of P2X7 attenuates wound healing in a
representative experiment. HCLE cells transfected with control (non-targeting siRNA) or siRNA targeted to P2X7 receptor were cultured to confluence.
Unsupplemented media or media with 100 mM BzATP were added prior to injury. Slides were placed on a heated stage in an environmental chamber
at 37uC and 5% CO2. Scratch wounds were made and contiguous images were taken every 20 min over 20 hr. Data are representative of 3
independent experiments. D. Percent wound closure from directed migration experiments at endpoint are presented as mean +/2 SEM. Significance
was determined by ANOVA followed by Tukey posthoc test: **p,0.001. E. HCLE cells transfected with control (non-targeting siRNA) or siRNA
targeted to P2X7 receptor were cultured to confluence. Real time RT-PCR was performed and relative expression of the indicated receptors was
determined using the DDCT method. The average relative expression of 3 independent experiments +/2 SEM is presented. Significance was
determined by Student’s test: **p,0.004. F. Parallel experiments to E. were conducted and cultures were lysed and equivalent amounts of protein
resolved by SDS-PAGE and immunoblotted with antibodies directed to P2X7 and P2X4 receptors.
doi:10.1371/journal.pone.0028541.g002
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milieu and not the result of P2Y activation and release of calcium
from intracellular stores [3]. In the presence of extracellular Mg
2+
the increase in fluorescence was reduced from 241.5618.3% to
134.6614.2% and in the presence of extracellular Zn
2+ the
response was attenuated further (66.6616.7%) (Figure 1A). These
changes observed in the presence of extracellular cations are
considered a hallmark of P2X7 activation and demonstrate
canonical activation [4,36–38]. Additional Ca
2+ imaging exper-
iments were performed in which cells were stimulated with
BzATP or ATP for 2 min, washed with HEPES-buffered saline
for 2 min to restore intracellular Ca
2+ levels back to baseline and
then stimulated with a second agonist for 2 min. When HCLE
cells were stimulated with ATP followed by BzATP there was a
significant diminished response to the second stimulus compared
to BzATP alone. However, when the treatments were reversed,
BzATP did not desensitize the ATP response (Figure 1B, C).
When cells were repeatedly stimulated with BzATP there was no
desensitization compared to stimulation with ATP, UTP or ADP
[38]. Together these data support the evidence for canonical
receptor activity.
The Ca
2+ response elicited by BzATP was inhibited by
A438079, a highly selective competitive P2X7 inhibitor in a dose
dependent manner (Figure 1D). The IC50 of the inhibitor is 300
nM for human receptors and concentrations 50 fold greater were
used [39]. At 1 mM, A438079 inhibited the response by 27.4%,
and at 5 mM a 64.2% inhibition was achieved. Higher
concentrations were not used due to decreased specificity with
inhibition of pannexin-1 observed at 10 mM [40]. To confirm the
specificity of the inhibitor the response to ADP, a ligand for P2Y1
receptor, was examined. As expected there was no change in the
average percent increase in fluorescence upon stimulation with
ADP in the presence of 5 mM A438079 (Figure 1D).
Activation of P2X7 receptor mediates ERK1/2
phosphorylation indicating presence of the amino
terminus
Previously we showed that ATP is released by mechanical injury
and leads to ERK phosphorylation in a rapid and transient
manner. Furthermore, phosphorylation was attenuated when the
wound medium was supplemented with apyrase [41]. Since the
amino terminus of P2X7 contains the domain required for ERK
activation, cells were stimulated with BzATP and phosphorylation
of ERK was examined. When corneal epithelial cells were treated
with 100 mM BzATP a 4.9-fold increase in phosphorylation of
ERK was detected at 5 min compared to control (Figure 2A). The
minimum increase observed at 5 min was 4-fold with a maximum
of 10 fold, which compared to stimulation with other agonists and
wound media at 5 min [41].
Cell migration requires activation of P2X7 receptor
As we had previously shown that wound repair was impaired in
P2X7
2/2 mice [28], we asked if activation of the receptor could
induce cell motility and wound closure of epithelial cells. The first
set of experiments addressed whether BzATP acted as a potent
chemoattractant. Assays were performed at concentrations
previously shown to optimize motility [3]. In a representative
experiment, 258 cells per 1.48 mm
2 migrated towards BzATP
(10 mM) compared to only 11 cells per 1.48 mm
2 in the control
binding buffer (Figure 2B). Scratch wound migration assays were
performed to address the role of BzATP and the P2X7 receptor
on wound repair in vitro. HCLE cells plated on chambered glass
slides were transfected with siRNA directed against P2X7 or non-
targeting (control) siRNA and grown to confluence. Scratch
wounds were made resulting in a cell-free area, and closure of the
wound was monitored every 20 min over a period of 20 hr on a
Zeiss LSM 510 200M confocal microscope with a heated stage
and CO2 regulated chamber. Previously we established a wound
size for which proliferation was not required to close the wound
[35]. Wound closure in cells transfected with control siRNA or
siRNA directed against P2X7 did not differ after 20 hr
(Figure 2D). The addition of BzATP enhanced the average
wound closure significantly in cells transfected with non-targeting
siRNA. There was no increase in cells transfected with P2X7
receptor siRNA and stimulated with BzATP (Figure 2C and D).
These indicate that the cells transfected with siRNA to the P2X7
did not respond to the agonist, while the cells transfected with the
non-targeting siRNA responded to the BzATP and migrated.
Real time RT-PCR was performed and showed significant
knockdown of the P2X7 receptor (Figure 2E). In addition western
blot analysis showed that the 75 kDa form was 12.3% of the non-
targeting control and the 42 kDa form was 12.5% of the non-
targeting control (Figure 2F). As P2X4 has been shown to be co-
expressed with P2X7, expression of P2X4 mRNA and protein in
cells transfected with siRNA to P2X7 was evaluated. There was
no significant decrease in mRNA or protein expression
(Figure 2E, F).
Figure 3. Cytotoxicity is not induced in epithelial cells
following P2X7 activation. A. MTT assay for cell toxicity was
performed on confluent HCLE cells. The response to control media,
100 mM BzATP or actinomycin D is presented as corrected absorbance
(570nm–690nm). Data are representative of 3 independent experiments
and are presented as +/2 SEM. (Significance was determined by ANOVA
followed by Tukey posthoc test; ** p,0.001. B. HCLE cells were
stimulated with 100 mM BzATP, 2 mg/ml actinomycin D or control media
lacking growth factors for 20 hr. Caspase activation was detected with
NucView 488 Live Cell Caspase-3 Assay (scale bar =50 mm and applies
to all 3 images). Images are representative of 5 independent
experiments.
doi:10.1371/journal.pone.0028541.g003
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cytotoxicity: a canonical activity of the receptor
The results presented thus far indicate that the mobilization of
Ca
2+ following stimulation with BzATP is canonical. However, the
ability of BzATP to stimulate wound repair and cell migration
instead of cell death is indicative of a non-canonical P2X7
response. Therefore, we examined the ability of BzATP to induce
a cytotoxic response in corneal epithelial cells using the cell
viability MTT assay. Confluent cells stimulated with BzATP
showed no detectable reduction in viability compared to untreated
controls. When the experiment was performed in the presence of
actinomycin D for 20 hr, there was an 80% reduction (Figure 3A).
To further examine the ability of BzATP to induce a cytotoxic
response, the cleavage of caspase 3 was analyzed. Treatment with
100 mM BzATP for 5 min, 10 min, 15 min, 4 hr, or 20 hr did not
induce cleavage of caspase 3 significantly over control. Actinomy-
cin D (2 mg/ml) was used as a positive control and induction of
caspase 3 was observed 20 hr following treatment (Figure 3B).
Confirmatory experiments performed under similar conditions
demonstrated lack of DNA ladder degradation (data not shown).
These data suggest that the non-canonical response may indicate
that the receptor is expressed as a variant form in these cells.
Large molecule dye uptake upon BzATP stimulation does
not occur in epithelial monolayer cultures
Another canonical activity associated with the P2X7 receptor is
the ability of BzATP to cause formation of large pores.
Specifically, pore formation has been linked to the C-terminus of
P2X7 [10,11]. To determine if pore formation occurred, HCLE
cells were stimulated and uptake of ethidium bromide (EtBr) a low
molecular weight dye (394 Da) or ToPro-3 a high molecular
weight dye (671 Da) was examined over time. Uptake of EtBr was
determined in confluent cultures using live cell microscopy at 37uC
and 5% CO2 in the presence and absence of BzATP (Figure 4).
When cells were stimulated with BzATP, uptake of EtBr was
observed in 67% of HCLEs and 60% of IMR90 cells. However,
initial uptake by IMR90 cells occurred more rapidly (Figure 4 and
associated Table). Furthermore when IMR90 cells, a cell line
known to undergo apoptosis [42], were stimulated with
BzATP65.4% of the cells took up ToPro-3 (671 Da) (Figure 4).
If HCLE cells were indeed forming a large pore, uptake of ToPro-
3 (671 Da) would be expected in response to BzATP and it was not
observed in equivalent monolayer cultures (Figure 4). Epithelial
cells were also examined for membrane blebbing during dye
uptake experiments, as this is another hallmark characteristic of
canonical P2X7 receptor activity attributed to the carboxyl
terminus [43–45]. We found that as long as the experiments were
performed in an environmental chamber at 37uC and 5% CO2
there was no indication of membrane blebbing in response to
BzATP in the live cell images and micrographs of epithelial cells
(Figure 4). Together these data suggest that the P2X7 receptor may
be expressed as a variant form in epithelial cells and that the
expression may be cell-type specific.
Expression of P2X7 receptor full-length and truncated
forms by epithelial cells
As the response to BzATP indicated the presence of both
canonical and non-canonical P2X7 receptor induced activity in
corneal epithelial cells, the expression profile of P2Y and P2X
receptors was determined. RT-PCR revealed the presence of P2Y
Figure 4. Confluent monolayer corneal epithelial cells do not form large pores when stimulated with BzATP. HCLE or IMR90 cells were
cultured and stimulated with control media or media containing 100 mM BzATP in the presence of EtBr or ToPro-3 and imaged over 20 min while
maintained at 37uC and 5% CO2 in an environmental chamber on a Zeiss LSM 510 confocal microscope. Representative images are of cells after
20 min BzATP with EtBr (EtBr) or BzATP with ToPro-3 (ToPro)(Scale bar =50 mm). Control treated cells in the presence of EtBr are shown (Control).
ToPro-3 is detected in IMR90 cells and only detected in HCLE cells being shed. The time to initial EtBr uptake is presented. Images are representative
of 3 independent experiments.
doi:10.1371/journal.pone.0028541.g004
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but not 1, 2, or 3) (Figure 5A). These data confirm that the Ca
2+
mobilization in response to BzATP in Figure 1 was not attributed
to P2X1 receptor, a receptor potentially activated by BzATP. As
we had evidence of non-canonical activity we asked if the cells
expressed a variant form of the P2X7 receptor instead of or in
addition to the full-length form. PCR was performed to amplify
the 13 exons of P2X7 from genomic DNA extracted from HCLE
cells. All exons were present (Figure 5B) and the specificity of the
primers was confirmed by sequencing of the products. Although
some single nucleotide polymorphisms were detected, none were
reported to have effects on protein function (data not shown).
Thus, the corneal epithelium has the ability to express a full-length
transcript containing all exons. To further investigate, additional
PCR was performed using primers that anneal to variants f and j
[12]. As these variants lack exon 8, and the primers used span the
deleted sequence, a product would not be detected if exon 8 was
present (Figure 5C). The PCR product of the expected size was
amplified and the product was sequenced and confirmed to be
P2X7. The splicing of variant f does not lead to a C-terminal
truncation but to a truncation of the N-terminus. Since BzATP
causes enhanced pERK, a function of the N-terminus, it is unlikely
that P2X7f is the receptor being expressed in HCLE cells.
In additional experiments northern and western blot analysis
revealed the presence of both full-length and variant forms of the
P2X7 receptor. Northern blot analysis was performed on IMR90
cells (cells that exhibit large pore formation) and epithelial cells
(Figure 6). Since the reported transcript sizes of several of the P2X7
receptor variants do not differ greatly from 18s rRNA, twice
purified mRNA was used for the northern blot (Figure 6A).
Ribosomal RNA was detected only in the total RNA fraction and
was completely removed from the mRNA samples (Figure 6A). In
the northern blot, both epithelial and IMR90 cells expressed a
transcript of the same length; however, the epithelial cells
expressed an additional transcript of a smaller size (Figure 6B).
Previously established primer sequences were used to determine
the expression of the j variant mRNA [12]. There were detectable
changes in expression of the full-length and variant transcripts
over time in HCLE cells (Figure 6C). In addition protein lysates
from IMR90 cells and epithelial cells were examined for
expression of P2X7 using western blot analysis and only the full-
length 75 kDa form was detected in IMR90 cells (Figure 6D). In
contrast, in HCLE cells the 75 kDa form was present in addition
to a 42 kDa form, that we hypothesize corresponds to the j variant
(Figure 6E). Specificity of the antibody to the P2X7 receptor was
confirmed with non-immune rabbit IgG and peptide competition
(data not shown).
The expression of the P2X7 multimers was examined using
western blot analysis on cross-linked protein lysates. After
treatment with formaldehyde the presence of a homotrimer of
full length receptor (220 kDa) and heterotrimers along with homo-
and heterodimers were detected at 65
oC, and the 75 kDa form
was minimal (Figure 6E). When the cross-linked lysates were
brought to 95uC to break the crosslinks, the 75 kDa form is
increased and there is a decrease in the higher molecular weight
complexes (Figure 6E inset). Together these indicate that corneal
epithelial cells have the ability to express both homo- and
heterotrimers.
Expression of P2X7 receptor is altered with stratification
and disease
To determine if there is a change in expression when cells were
transitioned from a monolayer to stratified state, the expression of
the P2X7 receptor was determined over 8 days. While we showed
the presence of the full length and truncated forms in Figure 6E,
we asked if the transition to stratification resulted in a change in
the ratio of the forms. The 75 kDa P2X7 form increased after the
stratification regime was initiated and remained elevated through
day 7, compared to the 42 kDa form that decreased at 5 days and
remained low (Figure 7A). A similar switch in the ratio of 75 and
42 kDa was confirmed in primary epithelial cells (data not shown).
Expression was correlated to total P2X7 receptor mRNA over the
same time period (Figure 7B). The increase in P2X7 mRNA was
detected prior to the enhanced expression of the 75 kDa protein
and decreased after stratification. The uptake of ToPro-3 was
observed in some apical cells of the stratified cultures stimulated
with BzATP (see arrows) compared to unstimulated and confluent
cultures (Figure 7C). The uptake is correlated with the expression
of the full length form and the decrease in the variant. In addition
Ki67 mRNA, a marker of proliferation, decreased to negligible
levels over the same time course (Figure 7D). Together, these
indicate that as the cells stratify there is less proliferation and that
the apical cells display uptake of the ToPro-3, consistent with an
increase in expression of full length receptor.
To determine if expression of the P2X7 receptor was altered in a
pathology in which wound repair and matrix organization is
known to be altered, we examined diabetic corneal epithelium.
The P2X7 receptor mRNA level was compared in age-matched
diabetic and control non-diabetic corneas. The diabetic tissue
showed a 4.4 fold increase in P2X7 mRNA over non-diabetic
control that was significant (Figure 8). Furthermore there was an
increased trend in expression of P2X7j receptor mRNA. Unlike the
Figure 5. Expression of receptor transcripts in epithelial cells.
A. RT-PCR was performed on HCLE mRNA showing presence of P2Y 1, 2,
4, 6, 11, and 12 receptor transcripts and P2X 4, 5, 6, and 7 receptor
transcripts. GAPDH is included as internal control. B. PCR was
performed on genomic DNA using exon specific primers. C. RT-PCR
was performed on HCLE mRNA using primers that spanned exon 8 (to
amplify variants f and j), showing an expected product size of 169 bp.
GAPDH was amplified as an internal control. All products were
sequenced and verified. Data is representative of a minimum of 3
independent experiments.
doi:10.1371/journal.pone.0028541.g005
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28541Figure 6. HCLEs express a full length and truncated P2X7 mRNA transcript and protein. A. mRNA was purified from total RNA of HCLE and
IMR90 cells cultured for 72 hours by twice passing over an oligo-dT column. Purity was confirmed by methylene blue staining of nytran filter
following transfer (note lack of rRNA in mRNA lanes). B. Northern blot analysis of HCLE and IMR90 mRNA from 72 hour cultures. The probe used was
generated by PCR amplification of a consensus region in all P2X7 variants. The relative position of 18s rRNA is indicated and the smaller transcript
expressed by epithelial cells is indicated (arrow). C. Expression of P2X7 and P2X7j mRNA transcript over a 72 hour incubation. Relative expression was
determined using the DDCT method. D. Expression of P2X7 receptor by IMR90 cells. Cells were cultured for 72 hours, lysed and protein was resolved
by SDS-PAGE (12%) and immunoblotted with anti-P2X7. E. Expression of P2X7 receptor by HCLE cells. Cells were cultured for 72 hours, lysed and
protein was resolved by SDS-PAGE (12%) and immunoblotted with anti-P2X7. Hetero- and homotrimers are identified on crosslinking gels. Epithelial
cells were cultured for 72 hours, incubated in situ in the presence of formaldehyde, lysed and incubated at 65uCo r9 5 uC to maintain or break
crosslinks. Inset – equivalent experiment resolved by SDS-PAGE (8%) and immunoblotted with anti-P2X7. Data is representative of a minimum of 3
experiments.
doi:10.1371/journal.pone.0028541.g006
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a 3.8 fold increase in Ki67 mRNA.
Discussion
Our results demonstrate that a normal healthy tissue such as
corneal epithelium expresses one or more P2X7 splice variants.
We demonstrate that the diabetic cornea displays significantly
enhanced expression of P2X7 receptor and variant transcript
compared to control. Our data indicate that the P2X7 receptor in
the corneal epithelium is expressed as both full-length and variant
forms and displays canonical and non-canonical activity. In Ca
2+
mobilization experiments, BzATP induces a canonical response in
control cultures in the presence of Mg
2+ or Zn
2+, or in the absence
of extracelluar Ca
2+. We demonstrated that P2X 4, 5, 6, and 7
receptor transcripts are expressed indicating that desensitization of
the BzATP response following stimulation with ATP is not a P2X1
receptor mediated response since it is not present [4]. In addition,
we have shown that as cells transition from monolayer to stratified
Figure 7. Expression of P2X7 receptor changes with stratifica-
tion. A. Stratification was induced after day 4 (arrow) and cells were
cultured for 4 additional days. Cells were lysed and equivalent amounts
of protein were resolved by SDS-PAGE and immunoblotted with anti-
P2X7. Representative blot is shown. Quantification of 75 kDa and
42 kDa protein are graphed as densitometric values relative to b-actin.
Data is representative of a minimum of 4 independent experiments. B.
Relative expression of P2X7 mRNA was determined using the DDCT
method and the average of 3 independent cultures +/2 SEM is
presented. C. Apical cells in stratified culture of HCLE cells at day 7
prestimulated with BzATP show minimal uptake of ToPro-3 using the
flow through aparatus. Cultures were prestimulated with BzATP for
5 minutes at which time ToPro-3 in the presence of BzATP was added.
Cells were imaged for an additional 20 minutes in the presence of
BzATP as described in Figure 4 (scale bar =50 mm). Arrow indicates
representative areas of uptake. Control experiments were performed in
the presence of HEPES buffer. D. Relative expression of Ki67 mRNA was
determined using the DDCT method and the average of 3 independent
cultures +/2 SEM is presented.
doi:10.1371/journal.pone.0028541.g007
Figure 8. Diabetic corneal epithelium displays enhanced P2X7
receptor expression compared to control non-diabetic corneal
epithelium. Central corneal epithelium from 6 samples of control and
diabetic were analyzed using real time PCR. Relative expression of the
P2X7 receptor (all variants), P2X7j variant receptor, and Ki67 were
determined using the DDCT method. The average relative expression of
6 independent samples +/2 SEM is presented. Significance was
determined by Student’s t-test: **p,0.002, *p,0.05 respectively.
doi:10.1371/journal.pone.0028541.g008
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uptake of ToPro-3 only in the most apical cells. These indicate a
functional change in phenotype as the confluent monolayer
cultures do not take up the ToPro-3 in the presence or absence of
BzATP. While previous studies have found variants in inflamma-
tory or cancerous cells, it has not been shown in healthy tissue as a
potential means for a single protein to modulate its cellular
phenotype.
Previous studies have described polymorphisms of P2X7 and a
number of mutations have been found in inflammatory cells
[46,47]. To date, eight variants resulting from alternative splicing
have been identified [10,48]. In the corneal epithelium all 13
exons of P2X7 from genomic DNA were found to be present along
with some single nucleotide polymorphisms. None were synony-
mous with the known loss of function or gain of function mutations
previously observed. As the corneal epithelium has the ability to
express a full-length transcript containing all exons, additional
PCR was performed using primers that anneal to variants f and j.
Since these variants lack exon 8, and the primers that were used
span the deleted sequence, a product would not be detected if exon
8 were maintained. Therefore the PCR product of the expected
size was amplified and the resulting product was sequenced and
confirmed to be P2X7. The region that was amplified contained a
frameshift that is common to both f and j. The splicing of variant f
does not lead to a C-terminal truncation but to a truncation of the
N-terminus. Since BzATP causes enhanced pERK, a function of
the N-terminus, it is unlikely that P2X7f is the receptor being
expressed in HCLE cells [10]. This is supported by data showing
that the cells do not display cytotoxicity and confluent cells do not
display dye uptake, which are all characteristics attributed to the
carboxyl terminus. Together these data indicate that epithelial
cells express a variant form of P2X7 receptor that we hypothesize
is j.
The corneal epithelium is an excellent model tissue for studying
the role of the P2X7 receptor and its variants. It is avascular, and
renewal of the corneal epithelium occurs via movement of basal
cells upward with shedding of the outermost epithelial layer into
the tear fluid or in migration after injury. Since there were changes
in the expression of truncated and full-length P2X7 receptor in
epithelial cells during the transition from confluent monolayers to
stratified cultures, we have begun to examine a number of
pathologies, specifically epithelium from age matched diabetic and
non-diabetic corneas. In diabetic tissue there are often changes in
the adhesion of epithelium to the basal lamina and impaired
wound repair [49]. We have shown altered wound repair and
faulty epithelial adhesion in the P2X7
2/2 mice [28]. While some
studies indicate that the P2X7 receptor is associated with
acceleration of Type I diabetes [50], other laboratories have
hypothesized that apoptosis is defective in Type I diabetes [51].
Our results demonstrate that the diabetic cornea displays
significantly enhanced expression of canonical P2X7 receptor
compared to control along with an increase in Ki67 mRNA.
These indicate that the variant mediates expression by acting as a
dominant negative and may explain why others have found
apoptosis to be defective in diabetes. Future studies will evaluate
the presence of full-length and truncated forms along with the
ability to form hetero- or homotrimers in normal and diseased
tissue.
While the P2X7j was detected in human cancerous cervical
epithelial cells [11,12], it is not unreasonable that it would be
expressed in corneal epithelium. Investigators have shown that
proteins change their regulation as the epithelium migrates to heal
a wound and then again when it stratifies [52]. As we detect more
of the 42 kDa form compared to the 75 kDa form in sparse cells
and the inverse in stratified cells, the expression may depend on
the state of epithelial integrity. In other words, the variant may
provide the tissue flexibility as it migrates and becomes stratified
during the process of wound closure and again as the cells move
apically and shed. In addition the diabetic tissue displays a trend
toward enhanced expression of the variant j compared to control.
It is possible that the corneal epithelium expresses other variants
and this will be a subject of future studies.
In other systems such as Xenopus laevis, the P2X7 receptor lacks
the C-terminus and experiments have demonstrated that it can
associate in varying ratios with the full-length receptor to form a
heterotrimeric receptor with altered activity [53]. Still others have
shown that P2X7j hetero-oligomerizes with the full-length receptor
resulting in antagonism of canonical activity [12]. Our physiolog-
ical and biochemical data support this premise as our crosslinking
studies indicate the presence of 220 kDa homotrimers along with
heterotrimers containing truncated forms. Therefore, although the
full-length receptor is expressed in the corneal epithelium, the
presence of truncated subunits in the trimeric assembly of the
receptor could inhibit the receptor’s ability to form a large pore
and induce a cytotoxic response. This is further supported by the
work of Becker et al. who showed that lack of a single carboxyl tail
in the trimeric P2X7 assembly is dominant-negative for receptor
activity [53]. Together these data suggest a heterogeneous
population of homo- and heterotrimeric receptors displaying a
phenotype that resembles that of the heterotrimer.
The observation that corneal epithelial cells express a P2X7
variant may ensure that cell death does not regularly occur and
disrupt corneal transparency and vision. While the epithelium
maintains the ability to express the full-length receptor we
hypothesize that in cell remodeling and/or pathology such as
diabetes, that the balance is altered and the variant becomes
upregulated. Further investigation into the expression and
regulation of the P2X7 receptor should reveal an elegant
mechanism for P2X7 to function as a multifaceted receptor that
can mediate cell proliferation and migration or cell death.
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